Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Celcuity Inc.

United States 2800 Campus Drive Suite 140, 55441-2630, United States

About the sponsor

Clinical research in metastatic castration-resistant prostate cancer focuses on treatment resistance and disease control in advanced prostate cancer.

  • Metastatic castration-resistant prostate cancer
  • Advanced prostate malignancy
  • Androgen receptor pathway targeting

The sponsor’s activity is centered on combination treatment strategies for men with progressive disease after hormonal therapy, with attention to outcomes linked to radiographic progression-free survival.

About Specializations

Celcuity Inc. runs clinical trials in conditions such as Hormone-refractory prostate cancer, Prostate cancer metastatic, Breast cancer, Hormone receptor positive breast cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Hormone-refractory prostate cancer+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Celcuity Inc.

Breast cancer+2

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Celcuity Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.